| Product ID |
Product Name |
CAS# |
Purity |
| Y1105836 |
TH-257 |
2244678-29-1 |
98% |
| Y1105838 |
AMG-009 |
1027847-67-1 |
98% |
| Y1105839 |
YUN27078 |
879127-07-8 |
98% |
| Y1105844 |
ATP synthase inhibitor 1 |
1023043-30-2 |
98% |
| Y1105845 |
Cotoin |
479-21-0 |
98% |
| Y1105846 |
mebeverine alcohol |
14367-47-6 |
98% |
| Y1105847 |
mebeverine hydrochloride |
2753-45-9 |
98% |
| Y1105852 |
1-((4'-(cyclopropylmethyl)-2-(pyridin-4-ylamino)-[4,5'-bipyrimidin]-2'-yl)amino)-2-methylpropan-2-ol |
1383716-46-8 |
98% |
| Y1105854 |
GRL0617 |
1093070-16-6 |
98% |
| Y1105856 |
ML417 |
1386162-69-1 |
98% |
| Y1105857 |
LUN09945 |
2414909-94-5 |
98% |
| Y1105863 |
Pexmetinib |
945614-12-0 |
98% |
| Y1105866 |
Asp7663 |
1190217-35-6 |
98% |
| Y1105880 |
SR-717 lithium |
2375421-09-1 |
98% |
| Y1105881 |
CGP60474 |
164658-13-3 |
98% |
| Y1105882 |
RU-301 |
1110873-99-8 |
98% |
| Y1105883 |
4,4,5,5-tetramethyl-2-(3-methylbenzo[b]thiophen-2-yl)-1,3,2-dioxaborolane |
1072811-91-6 |
95% |
| Y1105884 |
CID 1375606 |
313493-80-0 |
98% |
| Y1105889 |
MLT-748 |
1832578-30-9 |
98% |
| Y1105890 |
MLT-747 |
2097853-86-4 |
98% |
| Y1105891 |
RMC-4550 |
2172651-73-7 |
98% |
| Y1105892 |
BI-3802 |
2166387-65-9 |
98% |
| Y1105897 |
BAY-985 |
2409479-29-2 |
98% |
| Y1105898 |
P1446A05 |
1000023-04-0 |
98% |
| Y1105899 |
AZD4573 |
2057509-72-3 |
98% |
| Y1105900 |
BMS-986195 |
1912445-55-6 |
98% |
| Y1105906 |
1-isopropoxy-2-isopropylbenzene |
14366-59-7 |
95% |
| Y1105907 |
BLU-667 |
2097132-94-8 |
98% |
| Y1105908 |
GLPG2938 |
2130996-00-6 |
98% |
| Y1105909 |
SEN-12333 |
874450-44-9 |
98% |
| Y1105915 |
PSMA-11 |
1366302-52-4 |
98% |
| Y1105916 |
A2793 |
88349-90-0 |
98% |
| Y1105917 |
ALC-0315 |
2036272-55-4 |
98% |
| Y1105918 |
N-acetyl calicheamicin |
108212-76-6 |
98% |
| Y1105924 |
merafloxacin |
91188-00-0 |
98% |
| Y1105925 |
diosgenin palmitate |
4952-66-3 |
98% |
| Y1105926 |
XL092 |
2367004-54-2 |
98% |
| Y1105933 |
ARV-110 |
2222112-77-6 |
98% |
| Y1105934 |
DDO-5936 |
2355377-13-6 |
98% |
| Y1105940 |
PT2385 |
1672665-49-4 |
98% |
| Y1105942 |
CRT0273750 |
1979939-16-6 |
98% |
| Y1105943 |
(1S,9S)-1-amino-9-ethyl-5-fluoro-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl methanesulfonate |
169869-90-3 |
95% |
| Y1105950 |
etripamil |
1593673-23-4 |
98% |
| Y1105952 |
SU0268 |
2210228-45-6 |
98% |
| Y1105953 |
BMS-986242 |
1923844-48-7 |
98% |
| Y1105959 |
ABT-100 |
450839-40-4 |
98% |
| Y1105960 |
TC-O9311 |
444932-31-4 |
98% |
| Y1105961 |
YKL-05-099 |
1936529-65-5 |
98% |
| Y1105962 |
AH6809 |
33458-93-4 |
98% |
| Y1105967 |
LY3177833 |
1627696-51-8 |
98% |
| Y1105968 |
LH846 |
639052-78-1 |
98% |
| Y1105975 |
YY-20394 |
1702816-75-8 |
98% |
| Y1105984 |
TBAJ-587 |
2252316-16-6 |
98% |
| Y1105985 |
Lsp-249 |
1801253-04-2 |
98% |
| Y1105987 |
YUN88562 |
1514888-56-2 |
98% |
| Y1105993 |
BMS-817378 |
1174161-86-4 |
98% |
| Y1106000 |
Suggmadex Sodium |
343306-71-8 |
98% |
| Y1106001 |
Dalbavancin hydrochloride |
2227366-51-8 |
98% |
| Y1106003 |
Calicheamicin |
108212-75-5 |
98% |
| Y1106004 |
Basifungin |
127785-64-2 |
98% |
| Y1106009 |
didemnin B |
77327-05-0 |
98% |
| Y1106010 |
thailanstatin D |
1609105-89-6 |
98% |
| Y1106011 |
thailanstatin C |
1426953-24-3 |
98% |
| Y1106012 |
thailanstatin B |
1426953-23-2 |
98% |
| Y1106017 |
Leptomycin A |
87081-36-5 |
98% |
| Y1106018 |
Illudin S |
1149-99-1 |
98% |
| Y1106019 |
Illudin M |
1146-04-9 |
98% |
| Y1106021 |
Esperamicin |
99674-26-7 |
98% |
| Y1106035 |
Adalimumab |
331731-18-1 |
98% |
| Y1106036 |
Argatroban monohydrate |
141396-28-3 |
98% |
| Y1106043 |
Ggadobutrol |
770691-21-9 |
95% |
| Y1106044 |
Lanreotide acetate |
108736-35-2 |
98% |
| Y1106045 |
Leuprorelin acetate |
53714-56-0 |
98% |
| Y1106046 |
1-bromo-7-methoxynaphthalene |
83710-61-6 |
95% |
| Y1106053 |
2-bromo-3-methylisonicotinonitrile |
1260024-26-7 |
95% |
| Y1106054 |
4-nitrophenyl cyclopropylcarbamate |
444288-42-0 |
95% |
| Y1106055 |
3,4-dihydro-1H-isochromen-6-amine |
444588-39-0 |
95% |
| Y1106061 |
2,4-dimethylthiophen-3-amine hydrochloride |
2099705-25-4 |
95% |
| Y1106063 |
3-chloro-4-iodo-6-methoxypyridazine |
181355-91-9 |
95% |
| Y1106069 |
tert-butyl 3-amino-1-oxa-7-azaspiro[4.4]nonane-7-carboxylate hemioxalate |
|
95% |
| Y1106070 |
4-((17-amino-3,6,9,12,15-pentaoxaheptadecyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride |
2357117-23-6 |
95% |
| Y1106072 |
4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)phenyl)butan-1-one |
67987-08-0 |
95% |
| Y1106079 |
tert-butyl 4,4-bis(((phenylsulfonyl)oxy)methyl)piperidine-1-carboxylate |
|
95% |
| Y1106083 |
6-chloro-5-fluoropyridine-3-carbonitrile |
1020253-14-8 |
95% |
| Y1106090 |
6-methoxy-4-methylnicotinic acid |
943719-62-8 |
95% |
| Y1106092 |
tert-butyl 4-(3-(methoxycarbonyl)phenyl)piperidine-1-carboxylate |
1016980-41-8 |
95% |
| Y1106093 |
tert-butyl (E)-4-((hydroxyimino)methyl)piperidine-1-carboxylate |
190446-85-6 |
95% |
| Y1106094 |
3-bromo-2-chloro-6-fluorophenol |
943830-15-7 |
95% |
| Y1106100 |
1-(tert-butyl) 3-ethyl 4-(((trifluoromethyl)sulfonyl)oxy)piperidine-1,3-dicarboxylate |
176525-98-7 |
95% |
| Y1106101 |
(2,4,6-trifluoro-3-hydroxyphenyl)boronic acid |
1072951-37-1 |
95% |
| Y1106102 |
(1-oxo-2,3-dihydro-1H-inden-5-yl)boronic acid |
221006-64-0 |
95% |
| Y1106103 |
3,5-dibromo-2-chloro-6-(trifluoromethyl)pyridine |
1845716-91-7 |
95% |
| Y1106110 |
6-chloro-3-cyclobutyl-[1,2,4]triazolo[4,3-b]pyridazine |
1094292-72-4 |
95% |
| Y1106118 |
(R)-3-(methylsulfonyl)pyrrolidine hydrochloride |
1392745-31-1 |
95% |
| Y1106119 |
4-(benzyloxy)cyclohexane-1-carboxylic acid |
66500-40-1 |
95% |
| Y1106120 |
4-(tert-butoxycarbonyl)-1-methylpiperazine-2-carboxylic acid |
851882-93-4 |
95% |
| Y1106122 |
ethyl 2-oxo-2-(1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetate |
58199-07-8 |
95% |
| Y1106127 |
2,6-difluoro-4-formylbenzoic acid |
1242070-98-9 |
95% |
| Y1106129 |
4,4,5,5-tetramethyl-2-(oxan-4-ylmethyl)-1,3,2-dioxaborolane |
2249826-22-8 |
95% |
| Y1106130 |
ethyl 2-cyano-3-(2-fluorophenyl)propanoate |
773084-46-1 |
95% |